Literature DB >> 7557575

Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.

S Dubucquoi1, A Janin, O Klein, P Desreumaux, P Quandalle, A Cortot, M Capron, J F Colombel.   

Abstract

Endoscopic recurrences after radical surgery for Crohn's disease are useful for studying the pathogenesis of initial lesions of Crohn's disease. Factors predisposing to recurrence are poorly understood, but it has been shown that eosinophilic infiltration of the neoileum may occur within a few weeks of resection. The aim of this study was to compare, in nine patients having an ileocolectomy, the infiltration of eosinophils and their activation state in normal and diseased areas of the neoileum, three months after surgery. Tissue eosinophils were studied by histochemical methods and electron microscopy. Mucosal expression of interleukin 5 (IL 5), an important eosinophil activating factor was studied using in situ hybridisation. Sixty per cent of patients had endoscopic recurrence at three months. Eosinophil infiltration was more pronounced in diseased than in endoscopically normal areas and was associated with a high expression of IL 5 mRNA. Ultrastructural analysis showed features of eosinophil activation, but no cytotoxic lesions of surrounding inflammatory or epithelial cells. This study suggests that local synthesis of IL 5 associated with eosinophil activation in the tissues could participate in early mucosal damage in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557575      PMCID: PMC1382725          DOI: 10.1136/gut.37.2.242

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Eosinophils as mediators of antibody-dependent damage to schistosomula.

Authors:  A E Butterworth; R F Sturrock; V Houba; A A Mahmoud; A Sher; P H Rees
Journal:  Nature       Date:  1975-08-28       Impact factor: 49.962

2.  Activated eosinophils in chronic inflammatory bowel disease.

Authors:  M Y Choy; J A Walker-Smith; C B Williams; T T MacDonald
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

3.  Regulatory effect of cytokines on eosinophil degranulation.

Authors:  T Fujisawa; R Abu-Ghazaleh; H Kita; C J Sanderson; G J Gleich
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

4.  Mature human eosinophils have the capacity to express HLA-DR.

Authors:  D R Lucey; A Nicholson-Weller; P F Weller
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 5.  The eosinophilic leukocyte: structure and function.

Authors:  G J Gleich; C R Adolphson
Journal:  Adv Immunol       Date:  1986       Impact factor: 3.543

6.  Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.

Authors:  P Rutgeerts; K Geboes; G Vantrappen; R Kerremans; J L Coenegrachts; G Coremans
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

7.  Crohn's disease: transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature.

Authors:  A M Dvorak; R A Monahan; J E Osage; G R Dickersin
Journal:  Hum Pathol       Date:  1980-11       Impact factor: 3.466

8.  Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.

Authors:  G Torpier; J F Colombel; C Mathieu-Chandelier; M Capron; J P Dessaint; A Cortot; J C Paris; A Capron
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

9.  Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation.

Authors:  S D Mawhorter; J W Kazura; W H Boom
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

10.  Recombinant human interleukin 5 is a selective eosinophil chemoattractant.

Authors:  J M Wang; A Rambaldi; A Biondi; Z G Chen; C J Sanderson; A Mantovani
Journal:  Eur J Immunol       Date:  1989-04       Impact factor: 5.532

View more
  21 in total

1.  Eosinophil granulocytes are activated during the remission phase of ulcerative colitis.

Authors:  M Lampinen; A Rönnblom; K Amin; G Kristjansson; F Rorsman; P Sangfelt; B Säfsten; M Wagner; A Wanders; O Winqvist; M Carlson
Journal:  Gut       Date:  2005-05-10       Impact factor: 23.059

2.  Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/macrophage-derived CCL11.

Authors:  Amanda Waddell; Richard Ahrens; Kris Steinbrecher; Burke Donovan; Marc E Rothenberg; Ariel Munitz; Simon P Hogan
Journal:  J Immunol       Date:  2011-04-15       Impact factor: 5.422

3.  Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls.

Authors:  S C Bischoff; J Grabowsky; M P Manns
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

4.  Colitis in chronic granulomatous disease.

Authors:  M G Schäppi; V V Smith; D Goldblatt; K J Lindley; P J Milla
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

5.  Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease.

Authors:  J F Colombel; P Rutgeerts; H Malchow; M Jacyna; O H Nielsen; J Rask-Madsen; S Van Deventer; A Ferguson; P Desreumaux; A Forbes; K Geboes; L Melani; M Cohard
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

6.  Severe Eosinophilic Gastroenteritis in a Crohn's Disease Patient Treated With Infliximab and Adalimumab.

Authors:  Amanda Muir; Lea Surrey; Alyssa Kriegermeier; Ala Shaikhkalil; David A Piccoli
Journal:  Am J Gastroenterol       Date:  2016-03       Impact factor: 10.864

7.  IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis.

Authors:  M Lampinen; M Carlson; P Sangfelt; Y Taha; M Thörn; L Lööf; Y Raab; P Venge
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

Review 8.  The pathobiology of eosinophilic gastroenteritis of childhood: is it really the eosinophil, allergic mediated, or something else?

Authors:  Peter Ngo; Glenn Furuta; Wesley Burks
Journal:  Curr Gastroenterol Rep       Date:  2004-12

9.  Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype.

Authors:  Benjamin Click; Alyce M Anderson; Ioannis E Koutroubakis; Claudia Ramos Rivers; Dmitriy Babichenko; Jorge D Machicado; Douglas J Hartman; Jana G Hashash; Michael A Dunn; Marc Schwartz; Jason Swoger; Arthur Barrie; Sally E Wenzel; Miguel Regueiro; David G Binion
Journal:  Am J Gastroenterol       Date:  2017-11-07       Impact factor: 10.864

10.  Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse.

Authors:  Eoin N McNamee; Joshua D Wermers; Joanne C Masterson; Colm B Collins; Matthew D P Lebsack; Sophie Fillon; Zachary D Robinson; Joanna Grenawalt; James J Lee; Paul Jedlicka; Glenn T Furuta; Jesçs Rivera-Nieves
Journal:  Inflamm Bowel Dis       Date:  2010-05       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.